In one paragraphArticle in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
17 authors.
Giovanna PecoraroOncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), 6500 Bellinzona, Switzerland.ORCID 0009-0003-6743-6933 Marco CuzzocreaClinic of Nuclear Medicine, Institute of Integrated Diagnostics of Southern Switzerland (IDISI), Ente Ospedaliero Cantonale (EOC), 6500 Bellinzona, Switzerland.ORCID 0000-0002-8214-562X Cesare Michele IacovittiClinic of Nuclear Medicine, Institute of Integrated Diagnostics of Southern Switzerland (IDISI), Ente Ospedaliero Cantonale (EOC), 6500 Bellinzona, Switzerland.ORCID 0009-0000-8951-382X Marialuisa PuglisiOncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), 6500 Bellinzona, Switzerland.ORCID 0009-0008-0415-3107 Chiara MartinelloClinic of Nuclear Medicine, Institute of Integrated Diagnostics of Southern Switzerland (IDISI), Ente Ospedaliero Cantonale (EOC), 6500 Bellinzona, Switzerland.
Alberto De GiorgiOncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), 6500 Bellinzona, Switzerland.ORCID 0009-0002-0590-663X Luigi TortolaOncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), 6500 Bellinzona, Switzerland.
Hui-Ming LinOncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), 6500 Bellinzona, Switzerland.
Gianmarco LeoneOncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), 6500 Bellinzona, Switzerland.
Fabio TurcoOncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), 6500 Bellinzona, Switzerland.
Ricardo Pereira MestreOncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), 6500 Bellinzona, Switzerland.ORCID 0000-0002-3123-3697 Giorgio TregliaClinic of Nuclear Medicine, Institute of Integrated Diagnostics of Southern Switzerland (IDISI), Ente Ospedaliero Cantonale (EOC), 6500 Bellinzona, Switzerland.ORCID 0000-0001-9808-780X Ursula VoglOncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), 6500 Bellinzona, Switzerland.ORCID 0000-0002-2046-4246 Silke GillessenOncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), 6500 Bellinzona, Switzerland.ORCID 0000-0001-5746-6555 Martino PedraniOncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), 6500 Bellinzona, Switzerland.ORCID 0000-0002-8502-8226 Gaetano PaoneClinic of Nuclear Medicine, Institute of Integrated Diagnostics of Southern Switzerland (IDISI), Ente Ospedaliero Cantonale (EOC), 6500 Bellinzona, Switzerland.ORCID 0000-0003-2864-5364 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
[177Lu]Lu-PSMAexploratory modellingprostate cancerPSMA PET/CTPSMA PET-defined eligibilityradioligand therapytreatment eligibility
Identifiers
PMID42652200
PMCPMC13509732
What OpenQuestion holds
Textmetadata
Read underepoch 390